Meropenem Inj. 250mg/500mg/1g (Injectable)

Ertapenem for Injection is a new form of Carbapenem, which can be widely used on Gram-negative and Gram-positive anaerobes and aerobic.

Ertapenem for Injection is a new form of Carbapenem, which can be widely used on Gram-negative and Gram-positive anaerobes and aerobic.

Savior Lifetec Corporation manufactures sterile carbapenem antibiotic which includes meropenem (sterile bulk). It is a broad spectrum, beta-lactamase resistant, carbapenem antibiotic for parenteral administration. It readily penetrates through the cell wall of most gram-positive and gram-negative bacteria ...

Savior Lifetec Corporation manufactures sterile carbapenem antibiotic which includes meropenem and sodium carbonate (sterile bulk). It is a sterile, pyrogen-free, synthetic, broad spectrum, carbapenem antibiotic for intravenous administration. It is a broad spectrum, beta-lactamase resistant, carbapenem an...

Doripenem for Injection is a penem antibacterial indicated as single agent therapy for the treatment of:Complicated urinary tract infections (including pyelonephritis) and complicated intra-abdominal infections. 


This is a new development CDMO project. For more detail please contact info@sa...

Indication: Inhibition of premature LH surges

Development Status: API registration batch: Completed  FDF development: Completed  
FDF GMP registration batch: Q3 2022 
FDA Status 
DMF submission: Q4 2021 
 ANDA submi...

Indication: Inhibition of premature LH surges

Development Status:  API registration batch: Completed  
FDF development: Completed  
CMO partner survey: In progress
FDA Status:  DMF submission: Q4 2021  ANDA submission: TBD...

Indication: Treatment of schizophrenia  

Development Status: API registration batch: 2022.  
FDA Status: DMF submission, estimate in 2022


For more detail, please contact info@saviorlifetec.com.tw

Indication: Treatment of chronic idiopathic constipation (CIC)

Development Status: API registration batch: Q3 2021  FDF development: Q4 2021 
 FDF GMP registration batch: Q2 2022 
FDA Status: 
 DMF submission: Q2 2022 
 ANDA su...

In order to progress our business extension and bloom from a brand new image, we hereby announce to change our company name in Chinese from now on

Savior owns PIC/S GMP complied API & FDF factories and are approved by US FDA, MHRA, AEMPS, Taiwan FDA, MFDS, ANVISA...etc.

U.S. Food and Drug Administration (FDA) approved Savior’s ANDA of Ertapenem 1g in Mar, 2019.

Mission Statement
"Manufacturing quality products to meet the needs of patients worldwide while adding value to Savior employees, shareholders, and the Taiwan pharmaceutical industry in the creation of a healthier environment."